Cargando…
Acquired Factor XIII Deficiency Is Common during ECMO Therapy and Associated with Major Bleeding Events and Transfusion Requirements
Background: Bleeding events are frequent complications during extracorporeal membrane oxygenation therapy (ECMO). Objective: To determine the rate of acquired factor XIII deficiency and its association with major bleeding events and transfusion requirements in adults undergoing ECMO therapy. Materia...
Autores principales: | Noitz, Matthias, Brooks, Roxane, Szasz, Johannes, Jenner, Dennis, Böck, Carl, Krenner, Niklas, Dünser, Martin W., Meier, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299514/ https://www.ncbi.nlm.nih.gov/pubmed/37373805 http://dx.doi.org/10.3390/jcm12124115 |
Ejemplares similares
-
Refractory Duodenal Bleeding Ulcers Successfully Treated with Factor XIII Transfusion
por: Yamada, Yusuke, et al.
Publicado: (2021) -
The Limits of Acute Anemia
por: Tomić Mahečić, Tina, et al.
Publicado: (2022) -
Recurrent Bleeding after Head Trauma Caused by Acquired Factor XIII Deficiency
por: Wakabayashi, Nao, et al.
Publicado: (2022) -
The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing
por: Kleber, Christian, et al.
Publicado: (2022) -
Acquired Factor XIII Deficiency Inducing Recurrent and Fatal Bleeding, Description of a Case
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)